Kyle Chang Selected Research

B7-H1 Antigen

1/2018

Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kyle Chang Research Topics

Disease

14	Neoplasms (Cancer) 01/2024 - 11/2012
7	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2013
4	Carcinogenesis 03/2024 - 01/2017
3	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2021 - 01/2018
2	Adenoma (Adenomas) 01/2022 - 01/2017
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2019
2	Adenocarcinoma 01/2022 - 03/2021
2	Polyps 01/2021 - 01/2018
2	Inflammation (Inflammations) 01/2021 - 01/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 11/2012
1	Breast Neoplasms (Breast Cancer) 04/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	COVID-19 03/2021
1	Lung Neoplasms (Lung Cancer) 03/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Ulcerative Colitis 01/2021
1	Crohn Disease (Crohn's Disease) 01/2021
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2021
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2021
1	Residual Neoplasm 01/2021
1	Adenocarcinoma of Lung 01/2021
1	Lordosis 06/2019
1	Chronic Pancreatitis 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Turcot syndrome 01/2018
1	Microsatellite Instability 01/2013
1	Obesity 09/2011
1	Body Weight (Weight, Body) 09/2011
1	Stroke (Strokes) 09/2011
1	Bone Resorption 11/2005
1	Osteoporosis 04/2003

Drug/Important Bio-Agent (IBA)

4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
4	CytokinesIBA 01/2021 - 11/2005
3	VaccinesIBA 01/2024 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2021 - 06/2019
2	Sulindac (Copal)FDA LinkGeneric 01/2021 - 01/2017
1	Ado-Trastuzumab EmtansineIBA 04/2024
1	neratinibIBA 04/2024
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 03/2024
1	cyclopropapyrroloindoleIBA 01/2022
1	histone H3 trimethyl Lys4IBA 01/2022
1	HeterochromatinIBA 01/2022
1	Histones (Histone)IBA 01/2022
1	ChromatinIBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 03/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021
1	CarcinogensIBA 01/2021
1	Lipocalin-2IBA 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Naproxen (Naprosyn)FDA LinkGeneric 01/2021
1	Nucleic AcidsIBA 01/2021
1	EWS-FLI fusion proteinIBA 01/2021
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2021
1	Bexarotene (LGD1069)FDA Link 01/2021
1	Peptides (Polypeptides)IBA 01/2020
1	(+)-JQ1 compoundIBA 01/2019
1	sulforaphaneIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Interleukin-12 (IL 12)IBA 01/2018
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	B7-H1 AntigenIBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	CateninsIBA 01/2017
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2017
1	tolfenamic acidIBA 01/2017
1	SurvivinIBA 01/2017
1	Cyclin D1IBA 01/2017
1	Caspase 3 (Caspase-3)IBA 01/2017
1	5-nitro-2-(3-phenylpropylamino)benzoic acidIBA 01/2017
1	Calcibiotic Root Canal SealerIBA 01/2013
1	Insulin Receptor Substrate ProteinsIBA 09/2011
1	Glucose (Dextrose)FDA LinkGeneric 09/2011
1	Coloring Agents (Dyes)IBA 11/2005
1	Macrophage Colony-Stimulating FactorIBA 11/2005
1	Tartrate-Resistant Acid PhosphataseIBA 11/2005
1	ProstaglandinsIBA 04/2003
1	Prostaglandins EIBA 04/2003

Therapy/Procedure

3	Therapeutics 01/2022 - 09/2011
2	Immunotherapy 01/2020 - 01/2018
1	Chemoprevention 01/2021
1	Aftercare (After-Treatment) 01/2019
1	Precision Medicine 01/2019
1	Ovariectomy (Oophorectomy) 04/2003